ArticleAnnals of surgical oncology2025
Leveraging Deep Learning in Real-Time Intelligent Bladder Tumor Detection During Cystoscopy: A Diagnostic Study.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Artificial intelligence advances in cystoscopy and imaging for bladder cancer: a narrative review.The Canadian journal of urology · 2026Review
- Artificial intelligence and predictive tools in non-muscle invasive bladder cancer: a narrative review of current insights and advances.Translational andrology and urology · 2026Review
- Artificial intelligence in urological malignancy diagnosis and prognosis: current status and future prospects.The Canadian journal of urology · 2026Review
- Multimodal Large Language Models for Cystoscopic Image Interpretation and Bladder Lesion Classification: Comparative Study.Journal of medical Internet research · 2026Article
- Beyond Visualization: Advanced Imaging, Theragnostics and Biomarker Integration in Urothelial Bladder Cancer.Cancers · 2025Review
- ASO Author Reflections: AI-driven Personalization in Digital Medicine and Addressing Clinical Bottlenecks: Insights from a Prostate Cancer Application.Annals of surgical oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAccurate detection of bladder lesions during cystoscopy is crucial for early tumor diagnosis and recurrence monitoring. However, conventional visual inspection methods have low and inconsistent detection rates. This study aimed to evaluate the effectiveness of the HRNetV2 deep learning model for intelligent bladder lesion detection, focusing on its performance at different image resolutions. PATIENTS AND
methodsWe recruited 94 patients undergoing cystoscopy or transurethral resection of bladder tumor and collected 102 white-light cystoscopy videos between July 2022 and July 2023. Frames containing suspected bladder lesions were manually annotated. HRNetV2, a semantic segmentation model, was used to identify tumor-related morphological features. Images were categorized as high- or low-resolution, and the dataset was split into training and test sets (4:1 ratio). Diagnostic performance was assessed using sensitivity, precision, and mean Dice (mDice) score.
resultsA total of 33,657 frames were annotated. The overall sensitivity and precision for the test set were 91.6% and 91.3%, respectively, with an mDice score of 80.3%. In the high-resolution group, sensitivity and precision were 94.8% and 94.4%, while in the low-resolution group, they were 75.6% and 74.8%. The mDice scores for high- and low-resolution images were 84.7% and 56.6%, respectively.
conclusionsHRNetV2 demonstrated excellent performance, particularly with high-resolution images, offering high sensitivity and precision in bladder lesion detection. The results suggest that HRNetV2 has significant potential to improve detection accuracy in clinical practice. Future work should focus on optimizing the model further and testing it with larger, multicenter datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.